Locations:
Search IconSearch

Image of Note: 3-D Radiation-Free Navigation of the Aorta

Endovascular navigation technology clears first preclinical study

Centerline Biomedical IOPS

Endovascular repair of aortic aneurysms and dissections is critically dependent on optimal understanding of the patient’s vasculature. To that end, Cleveland Clinic Innovations spinoff company Centerline Biomedical Inc. is refining development of its Intraoperative Positioning System (IOPS), a novel endovascular navigation technology developed by Cleveland Clinic researchers.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

IOPS extracts the centerlines of the aorta and branch vessels from a patient’s CT and then mathematically constructs a high-quality three-dimensional model of the relevant vasculature, as shown in the image above. Electromagnetic tracking technology allows the model to be used in a GPS-like fashion to guide surgeons during minimally invasive endovascular aortic repairs, enabling less reliance on X-ray fluoroscopy.

The first preclinical in vivo study of IOPS was completed in May 2016 at Cleveland Clinic Lerner Research Institute. It demonstrated the system’s ability to provide non-radiation-based navigation with superior visualization compared with X-ray fluoroscopy, which is limited by its two-dimensional visualization and by the radiation exposure it confers on patients and providers.

“Preclinical evaluation verified the ability to use this navigation system in manipulating through the aorta and its branches in the absence of radiation-inducing fluoroscopy,” says Cleveland Clinic vascular surgeon Matthew Eagleton, MD, who led the study. Noting that catheters and guidewires were easily visualized on the IOPS display, he predicted that the system “will be a game changer in the era of endovascular therapy.”

Centerline Biomedical plans to submit IOPS for FDA review, with a target market entry in the third quarter of 2017.

Advertisement

Related Articles

illustration showing device inserted into heart chambers via blood vessels

IMPACT Trial Supports Safety, Feasibility of Preemptive LV Unloading in High-Risk Cardiac Surgery

First prospective study shows early extubation and low vasoactive/inotropic medication use

Dilated aorta

Reassessing Surgical Thresholds in Ascending Aortic Dilation

Height-indexed aortic measurements may better identify risk than diameter alone

gloved hands holding a human heart with podcast overlay

Heart Transplant: Initial Postoperative Care and Where the Field Is Heading (Podcast)

Insights from an expert cardiologist and a transplant surgeon

stylized illustration of the olfactory receptor

Olfactory Receptor Emerges as Therapeutic Target for Resistant Platelet Reactivity in Thrombosis

Findings promise to shape future antiplatelet drug development and treatment strategies

operating room during robotic surgery

The Right Time for Robotics in Cardiothoracic Surgery

How and why we're offering robot-assisted options for a full array of cardiac operations

illustrated blood vessel containing catheter stent with podcast overlay

Optimizing PCI Outcomes Across the Spectrum of Coronary Disease (Podcast)

Insights on common questions from referring providers

stylized heart and lungs with text overlay

Our Latest Outcomes in Thoracic Surgery, Lung Transplant, HOCM and Pericarditis

A snapshot of key stats from one of the world's busiest centers

scan of the inner organs of the human midsection

It’s Time for the EVAR Community to Retire the Term ‘Endoleak’

‘Sac flow’ is more precise and will ease unfounded patient concerns, experts argue

Ad